Yoon-A Kang, Ph.D.
Dr. Kang earned her B.A. in Biology at Yonsei University, Seoul, Korea. During her Master’s degree in the laboratory of Dr. Chae-ok Yun at Yonsei University, she developed a novel anticancer therapy using an artificial transcription factor targeting VEGF promoter and oncolytic adenovirus. For her Ph.D. training, she joined the laboratory of Dr. Emery Bresnick at the University of Wisconsin-Madison, where she studied how the GATA factor pathway regulates erythropoiesis. She conducted her postdoctoral research in the laboratory of Dr. Emmanuelle Passegué investigating the regulatory mechanisms underlying early myeloid lineage specification in the hematopoietic system. When not in the lab, Dr. Kang enjoys the outdoors and museums.
Sang-Eun Jung, Ph.D.
Postdoctoral Research Associate
Dr. Jung received her B.A., MS., and Ph.D. in Animal Science and Biotechnology from Chung-Ang University, Republic of Korea. She studied spermatogonial stem cells in the laboratory of Dr. Buom-Yong Ryu where she first found a novel phytochemical for the promotion of self-renewal in spermagonial stem cells during her master’s degree. For Ph.D. training, she developed male fertility preservation strategies to reduce cryoinjury via controlling signaling pathways such as autophagy, necroptosis, and apoptosis. She has strong interests in stem cell dysregulation and cancer. Dr. Jung enjoys playing a piano and composing music in her free time.
Jeeseung Kim, MS.
Jeeseung received her bachelor’s and master’s degrees in Integrative Bioscience and Biotechnology at Sejong University, Seoul, Korea. During her master’s degree in the laboratory of Dr. Chun Jeih Ryu, she identified the novel cell surface marker for mouse spermatogonial stem cells. She also studied the expression dynamics of mesenchymal stem cell surface markers, especially under its osteogenic differentiation. After graduation in February 2021, she worked in a R&D department of biotechnology venture companies. In her free time, she enjoys reading books sipping a cup of coffee while music plays.
Bin Choi, M.D.
Dr. Choi received her B.S. in Biomedical Engineering from Dongguk University and her MD from Ewha Womans University School of Medicine in Seoul, South Korea. In 2021, she worked at a Covid-19 vaccination center and a Covid-19 residential treatment center in Seoul. Her clinical experience during the pandemic led her to join Kang Lab in 2022 in the hopes of broadening her horizons by thoroughly experiencing each step of ‘from bench to bedside.’ Her research has been focused on the secretory regulation of multipotent progenitor cells in various microenvironments. She aims to investigate more about hematopoietic regulation in the context of perioperative inflammatory cytokine changes. She spends her free time visiting dog parks with her two lovely furbabies, Bambie and Dolly.